scholarly article | Q13442814 |
P50 | author | Elaine Jaffe | Q19647268 |
Lisa J Herrinton | Q91306296 | ||
P2093 | author name string | Liyan Liu | |
Oren Abramson | |||
P2860 | cites work | Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease | Q28285213 |
Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients | Q33349390 | ||
Hepatosplenic T cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990. | Q33949912 | ||
Hepatosplenic gamma/delta T-cell lymphoma: a report of two cases in immunocompromised patients, associated with isochromosome 7q. | Q41543854 | ||
Hepatosplenic T-gammadelta lymphoma in a patient with Crohn's disease treated with azathioprine | Q44398756 | ||
Hepatosplenic T-cell lymphoma in an adolescent patient after immunomodulator and biologic therapy for Crohn disease | Q45256545 | ||
Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease: update. | Q50600269 | ||
Infliximab, azathioprine, or combination therapy for Crohn's disease | Q56988763 | ||
Epidemiology of the Revised European-American Lymphoma Classification subtypes | Q77907591 | ||
P433 | issue | 1 | |
P921 | main subject | California | Q99 |
hepatosplenic T-cell lymphoma | Q5731794 | ||
P304 | page(s) | 49-52 | |
P577 | publication date | 2011-08-08 | |
P1433 | published in | Pharmacoepidemiology and Drug Safety | Q15759496 |
P1476 | title | The incidence of hepatosplenic T-cell lymphoma in a large managed care organization, with reference to anti-tumor necrosis factor therapy, Northern California, 2000-2006. | |
P478 | volume | 21 |
Q87454022 | Frequency and clonality of peripheral γδ T cells in psoriasis patients receiving anti-tumour necrosis factor-α therapy |
Q36812503 | Hepatosplenic T-Cell Lymphoma: A Population-Based Study Assessing Incidence and Association With Immune-Mediated Disease |
Q48160916 | Incidence, clinical findings, and survival of hepatosplenic T-cell lymphoma in the United States. |
Q36993224 | PET-CT for Evaluation of Spleen and Liver 18F-FDG Diffuse Uptake Without Lymph Node Enlargement in Lymphoma |
Q34065549 | Patient preferences for surgical versus medical therapy for ulcerative colitis |
Q27004241 | Peripheral T-cell and NK-cell lymphomas in the WHO classification: pearls and pitfalls |
Q37661741 | TCD4pos lymphocytosis in rheumatoid and psoriatic arthritis patients following TNFα blocking agents. |
Q35072606 | The benefit-to-risk balance of combining infliximab with azathioprine varies with age: a markov model |
Q33621267 | Use of thiopurines in inflammatory bowel disease: Safety issues |
Search more.